STING Agonist‐Loaded Nanoparticles Promotes Positive Regulation of Type I Interferon‐Dependent Radioimmunotherapy in Rectal Cancer
2023 · Advanced Science · 25 citations
https://doi.org/10.1002/advs.202307858
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
6
Papers
88
Citations
4
h-index
3
i10-index
Han Zhou is an academic researcher from Nantong University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Gut microbiota and health & Hepatitis C virus research. The author has an h-index of 4, co-authored 6 publications.
ORCID: 0000-0002-2051-600XClick to start Chat